Inventory

6 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Inventory

(6) Inventory

Inventory is stated at the lower of cost and net realizable value. Cost is determined using the first-in, first-out method. The Company expensed costs related to inventory within the Research and development line in the Consolidated Statements of Operations until it received approval from the FDA to market a product, at which time the Company commenced capitalization of costs relating to that product. Adjustments to inventory are determined at the raw material, sub-assemblies and finished goods levels to reflect obsolescence or impaired balances.

Inventory consists of the following:

	June 30, 2022			December 31, 2021
Raw materials	$	26		$	53
Sub-assemblies		4,011			4,656
Finished goods		1,655			645
		5,692			5,354
Provision for inventory obsolescence		(437	)		(352	)
Inventory	$	5,255		$	5,002